---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-006937"
form_type: "8-K"
ticker: "TELO"
cik: "0001971532"
company_name: "Telomir Pharmaceuticals, Inc."
filed_at: "2026-02-17T23:59:59+00:00"
generated_at: "2026-05-16T02:34:22.845900+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Telomir reports Telomir-1 induces near-complete tumor cell death in TNBC models; iron-rescue confirms mechanism

## Summary
- Near-complete tumor cell mortality in MDA-MB-468 (Basal-A/EGFR-high) TNBC cells at 72h.
- Significant partial reduction in HCC70 (Basal-like) and MDA-MB-231 (Claudin-low) cells.
- Supplemental iron attenuated Telomir-Zn-induced mortality, supporting iron-dependent mechanism.
- Prior zebrafish xenograft showed reduced growth/metastasis; IND submission expected Q1 2026.
- GLP safety studies in rats/dogs showed no adverse toxicity; IND-enabling activities ongoing.

## SEC filing metadata
- accession: 0001493152-26-006937
- form_type: 8-K
- ticker: TELO
- cik: 0001971532
- company_name: Telomir Pharmaceuticals, Inc.
- filed_at: 2026-02-17T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971532/000149315226006937/0001493152-26-006937-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971532/000149315226006937/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-006937
- JSON: https://secwatch.observer/filing/0001493152-26-006937.json
- Plain text: https://secwatch.observer/filing/0001493152-26-006937.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.